Effects of Levodopa-Carbidopa Intestinal Gel Compared with Optimized Medical Treatment on Nonmotor Symptoms in Advanced Parkinson’s Disease: INSIGHTS Study

<div>Study design (a) and patient flow diagram (b). Abbreviations: Anti-PD: anti-Parkinson’s disease, LCIG: levodopa-carbidopa intestinal gel, NJ: nasojejunal, OMT: optimized medical treatment, PEG-J: percutaneous endoscopic gastronomy with jejunal extension, <i>V</i>: visit, and <i>W</i>: week.</div>

Parkinson’s Disease

fig1

Figure 1

Figure 1: Effects of Levodopa-Carbidopa Intestinal Gel Compared with Optimized Medical Treatment on Nonmotor Symptoms in Advanced Parkinson’s Disease: INSIGHTS Study 

Figure 1 | Effects of Levodopa-Carbidopa Intestinal Gel Compared with Optimized Medical Treatment on Nonmotor Symptoms in Advanced Parkinson’s Disease: INSIGHTS Study 